Biote Corp BTMD.OQ BTMD.O is expected to show a rise in quarterly revenue when it reports results on May 7 for the period ending March 31 2025
The Irving Texas-based company is expected to report a 0.4% increase in revenue to $46.985 million from $46.8 million a year ago, according to the mean estimate from 6 analysts, based on LSEG data.
‚ÄčLSEG's mean analyst estimate for Biote Corp is for earnings of 7 cents per share.
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 6 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months. ‚Äč
Wall Street's median 12-month price target for Biote Corp is $7.50‚Äč, above‚Äč its last closing price of $3.25. ‚Äč‚Äč‚Äč
Previous quarterly performance (using preferred earnings measure in US dollars). ‚Äč
QUARTER ENDING
STARMINESMARTESTIMATE¬ģ
LSEG IBES ESTIMATE
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Dec. 31 2024
0.10
0.10
0.10
Met
0
Sep. 30 2024
0.08
0.09
0.33
Beat
266.7
Jun. 30 2024
0.08
0.09
-0.15
Missed
-273.1‚Äč
Mar. 31 2024
0.03
0.03
-0.06
Missed
-280
‚Äč‚ÄčDec. 31 2023
0.08
0.08
0.18
Beat
134.8
Sep. 30 2023
0.08
0.08
0.24
Beat
220‚Äč
Jun. 30 2023
0.09
0.10
-0.25
Missed
-363.2
Mar. 31 2023
0.09
0.09
-0.39
Missed
-533.3
This summary was machine generated May 5 at 21:30 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)